Home Newsfeeds JP Morgan Maintains Neutral on PVH, Raises Price Target to $95

JP Morgan Maintains Neutral on PVH, Raises Price Target to $95

JP Morgan analyst Matthew Boss maintains PVH (NYSE:PVH) with a Neutral and raises the price target from $77 to $95.

byBenzinga Newsdesk

January 23, 2023

1 minute read

JP Morgan analyst Matthew Boss maintains PVH (NYSE:PVH) with a Neutral and raises the price target from $77 to $95.

SEED Therapeutics, A Subsidiary Of BeyondSpring, Discloses Novel Molecular Glue IND Candidate For Cancer At “Targeted Protein Degradation Think Tank” Symposium

By Benzinga Newsdesk

October 26, 8:34 AM

SEED Therapeutics Inc. ("SEED"), a biotech company focused on harnessing and engineering Molecular Glues for targeted protein degradation (TPD) of disease-causing proteins, announced at its Monday, October 23, 2023

BYSI

Litecoin Hits One-Month Low Following Halving Event, Dogecoin Tumbles 4% As Well

By Mehab Qureshi

August 3, 3:01 AM

The price of Litecoin (CRYPTO: LTC), the native token of the Litecoin blockchain, dropped to its lowest level in a month on Wednesday afternoon, shortly after undergoing its highly anticipated “halving” event.

$DOGE